Abstract：Objective To investigate the phosphorus lowering effect of Lanthanum Carbonate in patients with end-stage renal disease and its effect on vascular calcification. Methods A total of 260 patients with end-stage renal disease admitted to Dingzhou People′s Hospital from January 2017 to January 2020 were selected as the research objects, and they were divided into the observation group (130 cases) and the control group (130 cases) by computer random drawing. Both groups were treated with hemodialysis, while patients in the observation group were treated with Lanthanum Carbonate, and patients in the control group were treated with Calcium Carbonate. Blood calcium, blood phosphorus,calcium phosphorus products and blood parathyroid hormone (PTH) levels were compared between the two groups at different time points (immediately after treatment, 2 weeks after treatment, 4 weeks after treatment, 8 weeks after treatment, and 12 weeks after treatment). The time when the blood phosphorus levels of the patients in the two groups returned to normal was recorded. The total incidence of adverse reactions in the two groups during medication was counted. Results After 2, 4, 8 and 12 weeks of treatment, serum calcium, blood phosphorus, calcium phosphorus products and blood PTH levels in the observation group were lower than those in the control group, serum calcium in the observation group after 4, 8 and 12 weeks of treatment were lower than those in the control group, and the differences were statistically significant (P＜0.05). The time of blood phosphorus levels in the observation group returning to normal was (30.59±5.61) d, which was shorter than (39.86±6.02) d in the control group, and the difference was statistically significant (P＜0.05). The total incidence of adverse reactions in the observation group (3.85%) was lower than that in the control group (13.07%), and the difference was statistically significant (P＜0.05). Conclusion Lanthanum Carbonate can significantly reduce the level of serum phosphorus in patients with end-stage renal disease, and has no significant effect on the level of serum calcium, which has high safety and is worthy of clinical use.
冯伟勋；韩伟；薛彩莉. 碳酸镧在终末期肾脏病患者中的降磷效果及对血管钙化的影响[J]. 中国当代医药, 2021, 28(19): 127-129转133.
FENG Wei-xun HAN Wei XUE Cai-li. Phosphorus lowering effect of Lanthanum Carbonate in patients with end-stage renal disease and its effect on vascular calcification. 中国当代医药, 2021, 28(19): 127-129转133.
京公网安备 11010502046607号